DaVita DVA
$161.03 +$4.69 (+3.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $161.03 0.00%
Open$157.86
Prev close$156.34
Day range$157.20 – $162.99
Volume730.2K
Market cap$10.13B
P/E (TTM)11.9
Dividend yield–
DVA Stock News
Headlines matching DaVita or the DVA ticker, most recent first.
- DaVita | 4: Statement of changes in beneficial ownership of securities-Officer Maughan David Paul
- BofA Adjusts Price Target on DaVita to $180 From $170
- TD Cowen Upgrades DaVita(DVA.US) to Buy Rating, Raises Target Price to $220 Positive
- Truist Financial Maintains DaVita(DVA.US) With Hold Rating, Announces Target Price $215
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Hinge Health, Inc. Class A (HNGE) and DaVita (DVA)
- Deutsche Bank Maintains DaVita(DVA.US) With Buy Rating, Raises Target Price to $265 Positive
- Truist Financial Maintains DaVita(DVA.US) With Hold Rating
- BofA Securities Maintains DaVita(DVA.US) With Sell Rating
- Daon Shares (002838): Consolidation synergies drive a sharp earnings surge; DVA commercialization enters the realization phase. Positive
- At US$180, Is DaVita Inc. (NYSE:DVA) Worth Looking At Closely?
- DaVita | 4: Statement of changes in beneficial ownership of securities
- Truist Financial Maintains DaVita(DVA.US) With Hold Rating, Maintains Target Price $215
- Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), Lifestance Health Group (LFST) and DaVita (DVA)
- Barclays Maintains DaVita(DVA.US) With Hold Rating, Raises Target Price to $224 Positive
- Truist Financial Maintains DaVita(DVA.US) With Hold Rating, Raises Target Price to $250 Positive
No comments yet — be the first to weigh in on DVA.
Sign in to join the discussion.